1-6 of 6
Abdullah M. Alrajhi
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Efficacy and Safety of AALL0232 Protocol in Adults with Acute Lymphoblastic Leukemia: Single Institution Experience

Abdullah M. Alrajhi, Mashael Alrouqi, Jude Howaidi, Mohammmad Alwadi, Hassan Alshehri, Imran K Tailor, Mohammed S Alnoamani, Nawal F Alshehry, Ibraheem H Motabi, Mohammed A Marei, Muhned Alhumaid
Journal: Blood
Blood (2023) 142 (Supplement 1): 7367.
https://doi.org/10.1182/blood-2023-189082
Published: 2023
Journal Articles

Discontinuation of Tyrosine Kinase Inhibitor Therapy and Treatment-Free Remission in Chronic-Phase Chronic Myeloid Leukemia: An Observational Retrospective Multi-Center Study

Aamer Aleem, Farjah Alqahtani, Ahmed Jamal, Nora A. Alkhudair, Mashail Alghafis, Hajar Wan Zuki Siti, Bader Alahmari, Hend Salama, Giamal Edin Gmati, Mohsen Alzahrani, Ayman Alhejazi, Naila A. Shaheen, Abdullah M Alrajhi, Mansour Alfayez, Zafar Iqbal, Ahmed Alaskar
Journal: Blood
Blood (2022) 140 (Supplement 1): 12220–12221.
https://doi.org/10.1182/blood-2022-168926
Published: 2022
Journal Articles

Conventional Versus Condensed Regimen of High Dose Cytarabine Consolidation in Acute Myeloid Leukemia

Abdullah M Alrajhi, Jude Howaidi, Adel Alnakhli, Fouad H. Alnajjar, Mansour Alfayez
Journal: Blood
Blood (2022) 140 (Supplement 1): 11729–11730.
https://doi.org/10.1182/blood-2022-166355
Published: 2022
Journal Articles

Safety and Efficacy of Azacitidine with Venetoclax for Newly Diagnosed Intensive Chemotherapy Ineligible, and Relapsed or Refractory Acute Myeloid Leukemia in Arab Population: A Single-Center, Retrospective Study

Mohammmad Alwadi, Jude Howaidi, Abdullah M Alrajhi, Adel Alnakhli, Mohammed A. Marei, Imran K. Tailor, Fouad H. Alnajjar, Syed Y. Altaf, Mohammed S. Alnoamani, Kamal Alzahrani, Hassan Alshehri, Ibraheem H. Motabi, Syed Ziauddin A Zaidi, Nawal F Alshehry, Mansour Alfayez
Journal: Blood
Blood (2021) 138 (Supplement 1): 4423.
https://doi.org/10.1182/blood-2021-153335
Published: 2021
Journal Articles

Efficacy of Brentuximab Vedotin and Bendamustine Combination in Relapsed/Refractory Hodgkin Lymphoma: Experience from a Tertiary Care Hospital

Abdullah M Alrajhi, Razan A. Aljalali, Lara H. Alghazi, Ibrahim Asiri, Adel Alnakhli, Fouad H. Alnajjar, Nawal F Alshehry, Ibraheem H. Motabi, Mohammed S. Alnoamani, Mohammed A. Marei, Mansour Alfayez, Imran K. Tailor
Journal: Blood
Blood (2021) 138 (Supplement 1): 4532.
https://doi.org/10.1182/blood-2021-152911
Published: 2021
Journal Articles

Polatuzumab Vedotin As a Salvage Treatment in Relapsed or Refractory DLBCL: Single Center Experience

Marwa Bin Morya, Mohammed A. Marei, Imran K. Tailor, Abdullah M Alrajhi, Adel Alnakhli, Foud Alnajjar, Mohammed S. Alnoamani, Hassan Alshehri, Ibraheem H. Motabi, Nawal AlShehry, Mansour Alfayez
Journal: Blood
Blood (2021) 138 (Supplement 1): 4558.
https://doi.org/10.1182/blood-2021-150242
Published: 2021